Streptozotocin-induced chromosomal aberrations, SCEs and mutations in CHO-9 parental cells and in EM-C11 mutant cell line
- 28 February 1995
- journal article
- Published by Elsevier BV in Mutation Research
- Vol. 326 (2), 227-234
- https://doi.org/10.1016/0027-5107(94)00172-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Tissue-specific induction of mutations by streptozotocin in vivoMutation Research, 1994
- Clastogenicity to the mouse bone marrow of the mouse germ cell genotoxin streptozotocinMutagenesis, 1992
- A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinomaCancer, 1991
- Influence of incorporated 5-bromodeoxyuridine on the frequencies of spontaneous and induced sister-chromatid exchanges, detected by immunological methodsMutation Research, 1986
- Mechanisms of nitrosourea-induced beta-cell damage. Alterations in DNADiabetes, 1986
- Chlorozocin. A diabetogenic analogue of streptozocin with dissimilar mechanisms of action on pancreatic beta cellsDiabetes, 1985
- Measurement of unscheduled DNA synthesis in rat kidney cells following in vivo treatment with genotoxic agentsEnvironmental Mutagenesis, 1985
- DNA strand breaks in pancreatic islets by administration of alloxan or streptozotocinBiochemical and Biophysical Research Communications, 1981
- Pancreatic beta cell toxicity by streptozotocin anomersDiabetes, 1977
- Structure of streptozotocinJournal of the American Chemical Society, 1967